{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T08:03:57Z","timestamp":1750320237577,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81403228"],"award-info":[{"award-number":["81403228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Provincial Science and Technology Project of Guangdong","award":["2013B021800225"],"award-info":[{"award-number":["2013B021800225"]}]},{"name":"Guangzhou Science and Technology Program","award":["201607010384"],"award-info":[{"award-number":["201607010384"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00277-016-2794-8","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:11:46Z","timestamp":1473811906000},"page":"1999-2007","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of the value of consecutive serum total light chain (sTLC) in patients diagnosed with diffuse large B cell lymphoma"],"prefix":"10.1007","volume":"95","author":[{"given":"Linzhu","family":"Zhai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songguo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongjian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"issue":"11","key":"2794_CR1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"The Non-Hodgkin\u2019s Lymphoma Classification Project","year":"1997","unstructured":"The Non-Hodgkin\u2019s Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 89(11):3909\u20133918","journal-title":"Blood"},{"issue":"8","key":"2794_CR2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/clinchem.2009.124370","volume":"55","author":"MM Giarin","year":"2009","unstructured":"Giarin MM, Giaccone L, Sorasio R, Sfiligoi C, Amoroso B, Cavallo F, Cipriani A, Palumbo A, Boccadoro M (2009) Serum free light chain ratio, total kappa\/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. Clin Chem 55(8):1510\u20131516","journal-title":"Clin Chem"},{"key":"2794_CR3","doi-asserted-by":"crossref","unstructured":"Tacchetti P, Cavo M, Rocchi S, Pezzi A, Pantani L, Brioli A, Testoni N, Terragna C, Zannetti BA, Mancuso K, Marzocchi G, Borsi E, Martello M, Rizzello I, Zamagni E (2016) Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens. Leukemia & lymphoma: 1-7.","DOI":"10.3109\/10428194.2015.1124994"},{"issue":"4","key":"2794_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.trsl.2006.11.001","volume":"149","author":"W Martin","year":"2007","unstructured":"Martin W, Abraham R, Shanafelt T, Clark RJ, Bone N, Geyer SM, Katzmann JA, Bradwell A, Kay NE, Witzig TE (2007) Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Transl Res 149(4):231\u2013235","journal-title":"Transl Res"},{"issue":"12","key":"2794_CR5","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1200\/JCO.2010.29.4413","volume":"29","author":"MJ Maurer","year":"2011","unstructured":"Maurer MJ, Micallef IN, Cerhan JR, Katzmann JA, Link BK, Colgan JP, Habermann TM, Inwards DJ, Markovic SN, Ansell SM, Porrata LF, Johnston PB, Nowakowski GS, Thompson CA, Gupta M, Syrbu SI, Kurtin PJ, Macon WR, Nikcevich DA, Witzig TE (2011) Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma. J Clin Oncol 29(12):1620\u20131626","journal-title":"J Clin Oncol"},{"issue":"1","key":"2794_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjh.12094","volume":"160","author":"M Furtado","year":"2013","unstructured":"Furtado M, Shah N, Levoguer A, Harding S, Rule S (2013) Abnormal serum free light chain ratio predicts poor overall survival in mantle cell lymphoma. Br J Haematol 160(1):63\u201369","journal-title":"Br J Haematol"},{"issue":"2","key":"2794_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2141.2008.07456.x","volume":"144","author":"G Pratt","year":"2009","unstructured":"Pratt G, Harding S, Holder R, Fegan C, Pepper C, Oscier D, Gardiner A, Bradwell AR, Mead G (2009) Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia. Br J Haematol 144(2):217\u2013222","journal-title":"Br J Haematol"},{"issue":"9","key":"2794_CR8","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3109\/10428194.2013.767456","volume":"54","author":"F Jardin","year":"2013","unstructured":"Jardin F, Delfau-Larue MH, Molina TJ, Copie-Bergman C, Briere J, Petrella T, Canioni D, Fabiani B, Jais JP, Figeac M, Leroy K, Mareschal S, Salles GA, Coiffier B, Delarue R, Peyrade F, Bosly A, Andre M, Ketterer N, Haioun C, Tilly H (2013) Immunoglobulin heavy chain\/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma. Leuk Lymphoma 54(9):1898\u20131907","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2794_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1):275\u2013282","journal-title":"Blood"},{"issue":"12","key":"2794_CR10","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835\u20133849","journal-title":"J Clin Oncol"},{"issue":"2","key":"2794_CR11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1373\/clinchem.2014.231985","volume":"61","author":"JA Katzmann","year":"2015","unstructured":"Katzmann JA, Willrich MA, Kohlhagen MC, Kyle RA, Murray DL, Snyder MR, Rajkumar SV, Dispenzieri A (2015) Monitoring IgA multiple myeloma: immunoglobulin heavy\/light chain assays. Clin Chem 61(2):360\u2013367","journal-title":"Clin Chem"},{"issue":"24","key":"2794_CR12","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1002\/cncr.28946","volume":"120","author":"EM Boyle","year":"2014","unstructured":"Boyle EM, Fouquet G, Guidez S, Bonnet S, Demarquette H, Dulery R, Herbaux C, Noel MP, Manier S, Schraen S, Onraed B, Faucompre JL, Hennache B, Petillon MO, Mathiot C, Avet-Loiseau H, Facon T, Harding SJ, Moreau P, Leleu X (2014) IgA kappa\/IgA lambda heavy\/light chain assessment in the management of patients with IgA myeloma. Cancer 120(24):3952\u20133957","journal-title":"Cancer"},{"issue":"3","key":"2794_CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3325\/cmj.2015.56.263","volume":"56","author":"J Batinic","year":"2015","unstructured":"Batinic J, Peric Z, Segulja D, Last J, Prijic S, Dubravcic K, Volaric L, Sertic D, Radman I, Basic-Kinda S, Matisic D, Batinic D, Labar B, Nemet D (2015) Immunoglobulin heavy\/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients. Croat Med J 56(3):263\u2013271","journal-title":"Croat Med J"},{"issue":"11","key":"2794_CR14","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.leukres.2014.09.006","volume":"38","author":"X Han","year":"2014","unstructured":"Han X, Wang J, Zhang N, Yao J, Feng Y, Li D, Liu P, Yang J, Zhou S, Qin Y, Yang S, Gui L, He X, Shi Y (2014) The prognostic utility and the association of serum light chains (free and total) and absolute lymphocyte count in patients with newly diagnosed diffuse large B-cell lymphoma. Leuk Res 38(11):1291\u20131298","journal-title":"Leuk Res"},{"issue":"1","key":"2794_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","volume":"101","author":"L Colomo","year":"2003","unstructured":"Colomo L, Lopez-Guillermo A, Perales M, Rives S, Martinez A, Bosch F, Colomer D, Falini B, Montserrat E, Campo E (2003) Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 101(1):78\u201384","journal-title":"Blood"},{"issue":"5","key":"2794_CR16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","volume":"208","author":"JJ Muris","year":"2006","unstructured":"Muris JJ, Meijer CJ, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ (2006) Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 208(5):714\u2013723","journal-title":"J Pathol"},{"issue":"17","key":"2794_CR17","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"WW Choi","year":"2009","unstructured":"Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, Liu Z, Gascoyne RD, Rosenwald A, Ott G, Rimsza LM, Campo E, Jaffe ES, Jaye DL, Staudt LM, Chan WC (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15(17):5494\u20135502","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2794_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","volume":"29","author":"PN Meyer","year":"2011","unstructured":"Meyer PN, Fu K, Greiner TC, Smith LM, Delabie J, Gascoyne RD, Ott G, Rosenwald A, Braziel RM, Campo E, Vose JM, Lenz G, Staudt LM, Chan WC, Weisenburger DD (2011) Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol 29(2):200\u2013207","journal-title":"J Clin Oncol"},{"issue":"1","key":"2794_CR19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bjhh.2015.11.003","volume":"38","author":"V Tietsche Moraes Hungria de","year":"2016","unstructured":"de Tietsche Moraes Hungria V, Allen S, Kampanis P, Soares EM (2016) Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies. Revista brasileira de hematologia e hemoterapia 38(1):37\u201343","journal-title":"Revista brasileira de hematologia e hemoterapia"},{"issue":"9","key":"2794_CR20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/clinchem\/48.9.1600","volume":"48","author":"G Marien","year":"2002","unstructured":"Marien G, Oris E, Bradwell AR, Blanckaert N, Bossuyt X (2002) Detection of monoclonal proteins in sera by capillary zone electrophoresis and free light chain measurements. Clin Chem 48(9):1600\u20131601","journal-title":"Clin Chem"},{"issue":"2","key":"2794_CR21","first-page":"113","volume":"29","author":"HF Chen","year":"2008","unstructured":"Chen HF, Hou J, Yuan ZG, Wang DX, Fu WJ, Chen YB (2008) Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma. Zhonghua Xue Ye Xue Za Zhi 29(2):113\u2013116","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"3","key":"2794_CR22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1515\/CCLM.2009.084","volume":"47","author":"SJ Harding","year":"2009","unstructured":"Harding SJ, Mead GP, Bradwell AR, Berard AM (2009) Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies. Clin Chem Lab Med 47(3):302\u2013304","journal-title":"Clin Chem Lab Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2794-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2794-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2794-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:45:13Z","timestamp":1601081113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2794-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2794"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2794-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2016,9,14]]}}}